Document is current
Any future updates will be listed below
-
Authors
Leung, Zoe
Ko, Frankie Chi Fat
Tey, Sze Keong
Kwong, Ernest Man Lok
Mao, Xiaowen
Liu, Bonnie Hei Man
Ma, Angel Po Yee
Fung, Yi Man Eva
Che, Chi-Ming
Wong, Danny Ka Ho
Lai, Ching Lung
Ng, Irene Oi-Lin
Yam, Judy Wai Ping https://orcid.org/0000-0002-5637-121X
-
Funding
Funding for this research was provided by:
University Research Committee, University of Hong Kong (201310159042)
Research Grants Council General Research Fund (17124814)
- License Information
-
More Information
Article History
Received: 27 August 2019
Accepted: 29 August 2019
First Online: 22 October 2019
Ethics approval and consent to participate
: All clinical tissue samples were obtained from Queen Mary Hospital, Hong Kong with informed consent. For the comparative analysis of Gal-1 levels, corresponding non-tumor liver tissue from each patient is considered as the control counterpart when compared to tumorous tissue for both, RNA and IHC tumor tissue analysis. Blood serum samples, for the determination of Gal-1 secretory concentration in patients, were provided by the Department of Surgery and Department of Medicine, The University of Hong Kong. The use of human samples has been approved by the Institutional Review Board of the University of Hong Kong/Hospital Authority Hong Kong West Cluster (HKU/HA HKW IRB). All animal work and procedures were followed according to the Animals (Control of Experiments) Ordinance (Hong Kong) and the Institute’s guidance from Laboratory Animal Unit.
: Not applicable.
: The authors declare that they have no competing interests.
